Arkolith/Insider Trading/PAHC/Form 4

David Glenn

Chief Financial OfficerPHIBRO ANIMAL HEALTH CORP (PAHC) · full profile →Form 4 · filed Feb 11, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 11, 2026Other(J)13K$51.63$647K52K
Feb 9, 2026Option exercise(M)30K——65K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2026Option exercise(M)30K—$0240K

Transaction Codes

J
Other acquisition / disposition
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-013378) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML